B6.129P2(C)-Igf2tm4.1Wrk/H

Status

Available to order

EMMA IDEM:01733
International strain nameB6.129P2(C)-Igf2tm4.1Wrk/H
Alternative nameS1.2Del
Strain typeTargeted Mutant Strains : Other targeted
Allele/Transgene symbolIgf2tm4.1Wrk
Gene/Transgene symbolIgf2

Information from provider

ProviderDr Wolf Reik
Provider affiliationThe Babraham Institute, Babraham, Cambridge, CB2 4PB
Genetic informationReplacement vector causing a small knock-out in a silencer region of the mouse Igf2 gene, in a repressor protein binding site, and leading to relative derepression of Igf2. In wild-type mice the Igf2 gene is imprinted on the maternal allele. The question addressed by this knock-out was to determine how much of the repression of the Igf2 maternal allele might be due to the presence of the upstream GCF2 (GC-binding factor 2, a known repression protein) binding site element located at HpaII site 4, in the differentially methylated region 1 (DMR1) of the Igf2 locus. The S1.2 DEL strain carries therefore a disruption of the GCF2 element caused by the insertion of a single loxP sequence within the GCF2 element. The GCF2 binding site mutation results in de-repression of the normally silent maternal allele (~3-fold more mRNA is produced compared with the wild-type maternal allele; see Eden et al. 2001, EMBO J, 20: 3518-3525 for more details). Note: the S1.2DEL strain was obtained by crossing the S1.2 Neo strain (EMMA strain EM:01732) with an ubiquitous expressor of the cre recombinase protein.
Phenotypic informationLoss of Igf2 imprinting.
References
  • An upstream repressor element plays a role in Igf2 imprinting.;Eden S, Constancia M, Hashimshony T, Dean W, Goldstein B, Johnson A C, Keshet I, Reik W, Cedar H, ;2001;The EMBO journal;20;3518-25; 11432838

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • abnormal imprinting / MGI
  • growth/size/body region phenotype / MGI
MGI phenotypes (gene matching)
  • delayed bone ossification / MGI
  • decreased bone mineral density / MGI
  • abnormal bone marrow cavity morphology / MGI
  • abnormal sternum morphology / MGI
  • abnormal xiphoid process morphology / MGI
  • abnormal cartilage development / MGI
  • abnormal heart morphology / MGI
  • abnormal tibia morphology / MGI
  • polydactyly / MGI
  • increased body weight / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • abnormal lens morphology / MGI
  • abnormal postnatal growth / MGI
  • postnatal growth retardation / MGI
  • abnormal skeleton development / MGI
  • increased heart weight / MGI
  • increased liver weight / MGI
  • abnormal lumbar vertebrae morphology / MGI
  • omphalocele / MGI
  • maternal imprinting / MGI
  • increased skeletal muscle size / MGI
  • abnormal fetal cardiomyocyte proliferation / MGI
  • abnormal imprinting / MGI
  • increased hepatocyte proliferation / MGI
  • increased kidney weight / MGI
  • decreased kidney weight / MGI
  • increased lean body mass / MGI
  • embryonic growth retardation / MGI
  • increased compact bone thickness / MGI
  • abnormal prenatal growth/weight/body size / MGI
  • fetal growth retardation / MGI
  • small placenta / MGI
  • abnormal placental transport / MGI
  • increased placenta weight / MGI
  • decreased placenta weight / MGI
  • decreased osteoblast cell number / MGI
  • abnormal heart ventricle morphology / MGI
  • growth/size/body region phenotype / MGI
  • abnormal circulating hormone level / MGI
  • abnormal skeleton morphology / MGI
  • abnormal heart septum morphology / MGI
  • abnormal osteoblast differentiation / MGI
  • abnormal osteoclast differentiation / MGI
  • delayed eyelid fusion / MGI
  • decreased fetal weight / MGI
  • increased fetal weight / MGI
  • decreased birth weight / MGI
  • decreased birth body size / MGI
  • prenatal growth retardation / MGI
  • abnormal bone trabecula morphology / MGI
  • abnormal compact bone lamellar structure / MGI
  • postnatal lethality, complete penetrance / MGI
  • lethality throughout fetal growth and development, incomplete penetrance / MGI
  • adrenal gland cyst / MGI

Literature references

  • An upstream repressor element plays a role in Igf2 imprinting.;Eden S, Constancia M, Hashimshony T, Dean W, Goldstein B, Johnson A C, Keshet I, Reik W, Cedar H, ;2001;The EMBO journal;20;3518-25; 11432838

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).